Investigation of method for prediction of therapeutic effect of infliximab initial therapy for inflammatory bowel disease
Not Applicable
- Conditions
- lcerative colitis, Crohn's disease
- Registration Number
- JPRN-UMIN000022726
- Lead Sponsor
- Ofuna Chuo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are considered not suitable for Infliximab use due to contraindication or considerable risks such as hypersensitivity to Infliximab. Other than above mentioned criteria, patients who are judged inappropriate by the doctor.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary end point was prediction of a clinical response at week 22.
- Secondary Outcome Measures
Name Time Method